Trial to Assess Implementation of New Research in a Primary Care Setting (TRAINS)
(TRAINS)
TRial to Assess Implementation of New Research in a Primary Care Setting (TRAINS): a Pragmatic Cluster Randomised Controlled Trial of an Educational Intervention to Promote Asthma Prescription Uptake in General Practitioner Practices
1 other identifier
interventional
1,389
1 country
1
Brief Summary
In England and Wales, unscheduled care for school-aged children with asthma significantly increases after their return to school in September, a trend linked with decreased asthma preventer prescriptions during the summer holidays. The PLEASANT study found that a reminder letter from GPs to parents of children with asthma led to a 30% increase in prescription uptake during August and reduced unscheduled medical visits from September to December. The TRAINS trial will now assess if informing GPs of PLEASANT findings would lead to its implementation. This pragmatic cluster randomised implementation trial will use routine data from Clinical Practice Research Datalink (CPRD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
January 11, 2022
CompletedFirst Posted
Study publicly available on registry
February 7, 2022
CompletedMay 18, 2023
December 1, 2021
2.2 years
January 11, 2022
May 16, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The proportion of children with asthma who have a prescription for an asthma preventer medication from 1st August 2021 to 30th September 2021.
prescription uptake of asthma preventer medication for children with asthma.
8 weeks
Secondary Outcomes (12)
The number of asthma preventer medication prescriptions per School-aged child with asthma patient from 1st August 2021 to 30th September 2021.
8 weeks
The number of prescription uptake of asthma preventer medication per patient in the month of August 2021.
4 weeks
The number of prescription uptake of asthma preventer medication per patient in the month of September 2021
4 weeks
The proportion of children who have a prescription for asthma preventer medication per patient in the month of August 2021.
4 weeks
The proportion of children who have a prescription for asthma preventer medication per patient in the month of September 2021.
4 weeks
- +7 more secondary outcomes
Study Arms (2)
Intervention arm
EXPERIMENTALGP practices randomised to the intervention will receive a mail and email about the result of the PLEASANT study and advising them to implement the study findings.
Usual care arm
NO INTERVENTIONGP practices randomised to control will not receive either mail or email and they will continue with usual care.
Interventions
Selected GP practices currently registered with CPRD will receive correspondence by both email and mail informing them about the result of the PLEASANT study and advising them how to implement what has been learnt. Included in the mailing would be a suggested letter and SMS text.
Eligibility Criteria
You may qualify if:
- General practices who are currently contributing part of the CPRD in England.
- School-aged children with asthma aged between 4 to 16 years old as of 1st September 2021 with a coded diagnosis of asthma who have been prescribed asthma medication in the last 12 months.
You may not qualify if:
- General practices that are not in England.
- General practices that are not included in the CPRD.
- Practices that cease to be part of the CPRD during the intervention time without contributing to the primary outcome.
- Practices that merge during the intervention (where the merging practices were in different study arms).
- School-aged children with asthma under 4 and over 16 years old as of 1st September 2021.
- Children with no asthma diagnosis
- Children with asthma who have not received a prescription for asthma medication. in the last 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Sheffield
Sheffield, United Kingdom
Related Publications (2)
Alyami RA, Simpson R, Oliver P, Julious SA. Evaluation of the impact of letters to GP practices to promote asthma prescription uptake in school-age children during summer (TRAINS study): a pragmatic cluster-randomised controlled trial. Lancet. 2023 Nov;402 Suppl 1:S22. doi: 10.1016/S0140-6736(23)02089-5.
PMID: 37997062DERIVEDAlyami RA, Simpson R, Oliver P, Julious SA. TRial to Assess Implementation of New research in a primary care Setting (TRAINS): study protocol for a pragmatic cluster randomised controlled trial of an educational intervention to promote asthma prescription uptake in general practitioner practices. Trials. 2022 Nov 17;23(1):947. doi: 10.1186/s13063-022-06864-y.
PMID: 36397087DERIVED
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Steven A Julious, PhD
University of Sheffield
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2022
First Posted
February 7, 2022
Study Start
August 1, 2019
Primary Completion
September 30, 2021
Study Completion
December 31, 2021
Last Updated
May 18, 2023
Record last verified: 2021-12